AC
JNJ icon

Avestar Capital’s Johnson & Johnson JNJ Stock Holding History

Avestar Capital’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,000
Closed -$1.61M – 470
2021
Q3 		$1.61M Buy
+10,000
New +$1.71M 0.21% 117

Other funds holding JNJ

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Avestar Capital's JNJ Position: Q2 2026 in Review

Avestar Capital reduced its Johnson & Johnson (JNJ) stake by 1.5% in Q2 2026, selling an estimated $66.7K and leaving 18,732 shares worth $4.76M. The position accounts for 0.27% of the portfolio, ranked #67.

Avestar Capital first reported a position in JNJ in Q4 2017 and has held it in 35 quarters since. 2,372 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Avestar Capital held 18,732 shares of Johnson & Johnson worth $4.76M as of Q2 2026.
  • Avestar Capital sold 286 Johnson & Johnson shares in Q2 2026, an estimated $66.7K.
  • Johnson & Johnson made up 0.27% of Avestar Capital's portfolio in Q2 2026, its #67 holding.
  • Avestar Capital first reported a position in Johnson & Johnson in Q4 2017 and has held it in 35 quarters since.
  • 2,372 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Avestar Capital's 13F filing for Q2 2026, filed 29 Jul 2026.